Samsung Biologics
207940.KS
#478
Rank
A$73.93 B
Marketcap
A$1,524
Share price
-1.45%
Change (1 day)
18.77%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2026 (TTM): A$2.47 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are A$3.08 Billion. In 2025 the company made an earning of A$2.26 Billion, an increase over its 2024 earnings that were of A$1.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$2.47 B9.4%
2025 A$2.26 B45.86%
2024 A$1.55 B12.54%
2023 A$1.37 B9.73%
2022 A$1.25 B67.4%
2021 A$0.75 B104%
2020 A$0.36 B57.54%
2019 A$0.23 B-45.41%
2018 A$0.42 B-389.75%
2017 -A$0.15 Billion-46.69%
2016 -A$0.28 Billion